Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87391 refers to the detection of the HIV-2 antigen using various immunoassay techniques. This procedure involves testing a blood or saliva sample to identify the presence of the human immunodeficiency virus type 2 (HIV-2) antigen. The immunoassay techniques utilized in this process include enzyme immunoassay (EIA), enzyme-linked immunosorbent assay (ELISA), fluorescence immunoassay (FIA), and immunochemiluminometric assay (IMCA). These methods are designed to detect even minute quantities of the HIV-2 antigen by employing specific antibodies that bind to the antigen in the sample. HIV-2 is a variant of the HIV virus that can lead to acquired immunodeficiency syndrome (AIDS), a condition characterized by the progressive failure of the immune system. The virus is primarily transmitted through sexual contact, but it can also be spread through unscreened blood transfusions, sharing of needles, and from mother to child during childbirth or breastfeeding. The testing process begins with the collection of a sample, which is then processed in a laboratory setting. The immunoassay techniques work by introducing a secondary enzyme-labeled antibody that binds to the antigen, resulting in a chromogenic reaction that produces a visible color change or fluorescence, indicating the presence of the HIV-2 antigen. The results can be reported as qualitative, indicating the presence or absence of the antigen, or semi-quantitative, providing a measure of the antigen concentration based on colorimetric readings. This code is specifically used for testing HIV-2, distinguishing it from other related codes that pertain to HIV-1 testing.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 87391 is indicated for the detection of the HIV-2 antigen in individuals who may be at risk for HIV infection. The following conditions or situations warrant the use of this test:
The procedure for CPT® Code 87391 involves several key steps to ensure accurate detection of the HIV-2 antigen:
After the procedure associated with CPT® Code 87391, the patient may receive counseling regarding the results of the test. If the test is positive, further confirmatory testing and medical evaluation are typically recommended to assess the patient's health status and determine the appropriate course of treatment. Patients may also be advised on preventive measures to reduce the risk of transmission. It is essential for healthcare providers to ensure that patients understand the implications of their test results and the importance of follow-up care. Additionally, patients should be informed about the potential for false positives or negatives and the need for retesting in certain circumstances.
| Short Descr | HIV-2 AG IA | Medium Descr | IAAD IA HIV-2 | Long Descr | Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-2 | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2022-01-01 | Changed | First appearance of change in codebook. |
| 2022-01-01 | Note | Grammatical correction. |
| 2021-01-01 | Changed | First appearance of change in CPT® Code Set. |
| 2020-10-06 | Changed | Code changed. |
| 2016-01-01 | Changed | Description Changed |
| 2011-01-01 | Changed | Short description changed. |
| 2007-01-01 | Changed | Code description changed. |
| 1998-01-01 | Added | First appearance in code book in 1998. |
Get instant expert-level medical coding assistance.